Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11169 - 11176 of 12009 results
DOL, IRS, and HHS Put the Brakes on Stand-Alone HRAs Used to Access Health Insurance Coverage in the Individual Market
February 1, 2013| Advisory| Viewpoint
FDA Will Not Appeal Second Circuit Decision in U.S. v. Caronia
January 29, 2013| Blog| Viewpoint
OCR Releases Sample Business Associate Agreement Provisions
January 29, 2013| Blog| Viewpoint
REMINDER -- Webinar: The New HIPAA Omnibus Rule and Your Liability: TOMORROW
January 29, 2013| Blog| Viewpoint
FCC Provides Guidance on Tower Site Collocation
January 29, 2013| Advisory| Viewpoint
Data Privacy Day 2013 - Passwords
January 28, 2013| Blog| Viewpoint
Hints of Bipartisan Cooperation on Health Issues in the Energy & Commerce Committee
January 28, 2013| Advisory| Viewpoint
Canada's Anti-Spam Law is a Step Closer
January 25, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|